DNAStar and the Oklahoma Medical Research Foundation (OMRF) have signed a broad site license agreement for the use of Lasergene sequence analysis software developed by the bioinformatics software company.
Under the terms of the site license, Lasergene will be available to an unlimited number of users at the foundation, which is located in Oklahoma City, OK, for a four-year time period. Founded in 1946, OMRF focuses much of its efforts in the search for the causes and cures for heart disease, Alzheimer’s and other brain diseases, cancer and diabetes.
Lasergene is a sequence analysis software that provides users with tools for performing a wide range of assembly, visualisation and analysis operations on data generated by conventional Sanger sequencing method as well as next generation techniques. The desktop software allows users to analyse samples ranging from small plasmids up to large bacterial genomes. Tools such as Lasergene provide scientists with information on the molecular issues associated with genetic disorders.
Lasergene is a suite of tools for molecular biologists and geneticists used primarily in the assembly and analysis of DNA and protein sequences. The software provides researchers with a broad range of analysis tools that can be used with traditional and next-generation sequence analysis projects.
